GlaxoSmithKline Reports Strong Full Year Numbers
Pharmaceutical giant GlaxoSmithKline has reported rising full year sales and profits, while pointing to a pipeline of new products that will help its performance in 2018. The company saw turnover rise 3% at constant exchange rates to £30.2 billion, while adjusted...
Read More